ALLMedicine™ Autoimmune Hepatitis Center
Research & Reviews 1,230 results
https://doi.org/10.1007/s10620-022-07525-5 10.1016/S0140-6736(12)62163-1 10.1056/NEJMra050408 10.1080/00365529850166284 10.1016/j.jhep.2015.06.030 10.1111/j.1365-2036.2009.04061.x 10.1111/liv.13960 10.1016/j.jhep.2013.10.035 10.1002/hep.30031 10.1111/apt.15111 10.1093/oxfordjournals.qjmed.a067264 10.1136/gut.16.11.876 10.1016/S0016-5085(19)33223-8 10.1016/S0140-6736(73)92125-9 10.1053/j.gastro.2010.06.046 10.1016/S1590-8658(11)60638-5 10.1016/j.jhep.2010.12.032 10.1136/bmj.311.6997.109 10.1191/1478088706qp063oa 10.1111/apt.14968 10.1111/apt.13794 10.2190/IL.18.3.e 10.1053/gast.2002.32993 10.1080/08870446.2011.565876 10.1177/160940691201100409
Digestive Diseases and Sciences; Lloyd C, Leighton J et. al.
May 18th, 2022 - Data show that patients with autoimmune hepatitis have significantly reduced quality-of-life and that corticosteroids carry marked side effects. This study explored patients' experiences of autoimmune hepatitis and its treatments; key aspects for ...
https://doi.org/10.12659/AOT.935938
Annals of Transplantation; Alissa DA, Alkortas D et. al.
May 18th, 2022 - BACKGROUND Tacrolimus is a calcineurin inhibitor (CNI) commonly used as an immunosuppressant to prevent the rejection of organ transplants. After liver transplantation, it can cause early neurological complications, known as early calcineurin inhi...
https://doi.org/10.1002/hep.32572
Hepatology (Baltimore, Md.); Efe C, Kulkarni AV et. al.
May 15th, 2022 - A few case reports of autoimmune hepatitis like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment response and outcomes of liver injury followi...
https://doi.org/10.1111/1756-185X.14331
International Journal of Rheumatic Diseases; Gomathy S, Panigrahi B et. al.
May 11th, 2022 - Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating central nervous system illness encountered in the setting of immunosuppressive conditions like human immunodeficiency virus / acquired immunodeficiency syndrome, autoimmune d...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088151
Seminars in Immunopathology; Liwinski T, Heinemann M et. al.
May 11th, 2022 - Autoimmune liver diseases are a group of immune-mediated liver diseases with three distinct entities, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. The interplay of genetic and environmental facto...
Guidelines 5 results
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.
Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.
Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...
https://doi.org/10.1002/hep.31065
Hepatology (Baltimore, Md.); Mack CL, Adams D et. al.
Dec 22nd, 2019 - Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.|2019|Mack CL,Adams D,Assis DN,Kerkar N,Manns MP,|diagnosis,drug therapy,
https://doi.org/10.1038/ajg.2016.517
The American Journal of Gastroenterology; Kwo PY, Cohen SM et. al.
Dec 21st, 2016 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...
https://doi.org/10.1002/hep.23584
Hepatology (Baltimore, Md.); Manns MP, Czaja AJ et. al.
Jun 1st, 2010 - Diagnosis and management of autoimmune hepatitis.|2010|Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,|blood,diagnosis,drug therapy,immunology,pathology,
Drugs 10 results see all →
Clinicaltrials.gov 17 results
https://clinicaltrials.gov/ct2/show/NCT05335603
Apr 19th, 2022 - Hepatic steatosis may cause inflammation and fibrosis within the liver potentially leading to end-stage liver disease cirrhosis, liver failure and death. The condition is associated with several other chronic liver diseases like autoimmune hepatit...
https://clinicaltrials.gov/ct2/show/NCT05293899
Mar 24th, 2022 - It has long been claimed that depression, and other psychiatric illness, might be a manifestation of immune dysregulation involving the Central nervous system. Depression is associated with a significantly increased risk of autoimmune disease comp...
https://clinicaltrials.gov/ct2/show/NCT05221411
Feb 3rd, 2022 - Rationale: The combination of azathioprine and prednisone is the first-line treatment for autoimmune hepatitis (AIH), a chronic inflammatory disease of the liver. Complete biochemical remission (CR) is the first treatment goal in autoimmune hepati...
https://clinicaltrials.gov/ct2/show/NCT04861571
Sep 28th, 2021 - Study design: The investigators plan to perform a non-controlled, non-randomized, open-label, pilot clinical trial to evaluate the effect of an 8-week VLCD intervention on NAFLD. The main variable of this study is the magnitude of liver steatosis ...
https://clinicaltrials.gov/ct2/show/NCT04281082
Sep 2nd, 2021 - Introduction: ICP is commolnly manifested in the 2nd and especially in the 3rd trimester of pregnancy. Pathogenesis of ICP is multifactorial implicating genetic, environmental and hormonologic factors. Prevalence of ICP varies. In certain populati...
News 93 results
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/97151
Feb 11th, 2022 - A case-control study revealed which patients were more likely to use herbal products for irritable bowel syndrome. (BMC Gastroenterology) Diabetes following a liver transplant was linked to cancer risk, a study from Italy found. (Annals of Hepatol...
https://www.medscape.com/viewarticle/964508
Dec 10th, 2021 - NEW YORK (Reuters Health) - Immune-mediated diseases were associated with an increased risk of local and systemic cancers, as well as total cancers, in a large cohort study, supporting the role of local and systemic immunoregulation in the develop...
https://www.medscape.com/viewarticle/961292
Nov 30th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, here with my great friend, Dr Paul Nelson Williams. Paul, what are we going to talk about today? Paul N. Williams, MD: In thes...
https://www.onclive.com/view/as-fda-review-approaches-finn-reflects-on-the-utility-of-pembrolizumab-nivolumab-in-hcc
Oct 6th, 2021 - Pembrolizumab (Keytruda) and nivolumab (Opdivo) represent valuable second-line treatment options for patients with hepatocellular carcinoma (HCC), despite not having met the end points of the confirmatory KEYNOTE-240 and CheckMate-459 trials, resp...
https://www.onclive.com/view/frontline-nivolumab-plus-chemo-shows-practice-changing-potential-in-gi-cancers
Oct 6th, 2021 - The combination of nivolumab (Opdivo) plus standard-of-care chemotherapy has demonstrated groundbreaking efficacy and tolerability in patients with PD-L1–positive advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and esophageal aden...
